Candriam S.C.A.

Position in CRL — Charles River Laboratories International, Inc.

CIK 1537014 STRASSEN, N4

Position in CRL

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$14,909,175

+$8,270,282 QoQ

Shares Held

86,430

+159.7% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $593,505,748 across 14 Diagnostics & Research names. CRL ranks #10 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	354,087	$174,044,383
2	A	Agilent Technologies, Inc.	1,157,090	$131,885,118
3	DHR	Danaher Corp /De/	275,951	$52,320,309
4	MEDP	Medpace Holdings, Inc.	103,349	$49,627,156
5	IQV	Iqvia Holdings Inc.	226,794	$38,677,448
6	IDXX	Idexx Laboratories Inc /De	64,015	$35,969,388
7	MTD	Mettler Toledo International Inc/	21,458	$27,062,829
8	DGX	Quest Diagnostics Inc	104,136	$20,408,573

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,909,175	86,430	+159.7%	Shares	Sole	2026-04-30
2025-12-31	$6,638,893	33,281	+1061.2%	Shares	Sole	2026-04-30
2023-03-31	$578,416	2,866	-44.4%	Shares	Sole	2023-05-12
2022-12-31	$1,122,838	5,153	-90.0%	Shares	Sole	2023-02-13
2022-09-30	$10,126,146	51,454	-4.4%	Shares	Sole	2022-11-10
2022-06-30	$11,513,082	53,807	-20.3%	Shares	Other	2022-08-03
2022-03-31	$19,176,493	67,530	-48.2%	Shares	Sole	2022-05-13
2021-12-31	$49,135,502	130,409	-40.9%	Shares	Other	2022-02-10
2021-09-30	$91,078,332	220,705	-7.3%	Shares	Sole	2021-11-09
2021-06-30	$88,095,337	238,147	+239.3%	Shares	Other	2021-07-20
2021-03-31	$20,340,269	70,180	+0.0%	Shares	Other	2021-04-29
2020-12-31	$17,532,426	70,169	+60.0%	Shares	Sole	2021-01-22
2020-09-30	$9,928,926	43,846	—	Shares	Sole	2020-10-19
No filing history on record for this holder in this stock.